Thursday, January 26, 2017

BRIEF-Auris Medical resumes enrollment in tactt3 phase 3 trial of Keyzilen

* Auris Medical resumes enrollment in tactt3 phase 3 trial

of keyzilen in acute and post-acute tinnitus

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)